PortfolioCortica
Why We Invested
Cortica is the nation’s leading whole-child service provider for autistic and neurodivergent children – providing access to a fully dedicated, physician-led care team covering a broad range of pediatric expertise, including neurologists, behavior analysts, speech pathologists, physical occupational therapists and more.
The San Diego-based company currently has a geographic footprint of 24 medical home clinics across eight states and offers medical care, developmental therapies, Applied Behavior Analysis therapy and family wellness counseling. Cortica's care model has shown improved outcomes across conditions that frequently co-occur with autism, including sleep disorders, seizures, psychiatric comorbidities, and gastrointestinal, communication, behavioral and sensorimotor issues — while utilizing less than 50 percent of standard applied behavioral analysis volumes, limiting the use of antipsychotic and stimulant medications and reducing emergency department and inpatient admissions.
Given that the prevalence of autism and other developmental disabilities continues to grow, this investment strategically supports Morgan Health’s commitment to testing and scaling solutions that address unmet needs in employer-sponsored health care.
“Families with autistic or neurodivergent children are often burdened by a highly fragmented, complex health care system. Delays in diagnosis, uncoordinated care across clinician teams and limited data to inform clinical measures leave people unsure where to turn for care or access the appropriate intervention for their child. Our investment in Cortica is aimed at reducing this burden — ensuring that more families have access to a singular, primary point of care so their children can get better faster.” – Dan Mendelson, CEO, Morgan Health